Is UnitedHealth’s Margin Going Back To What It Was?

UnitedHealth’s operating margin has dropped well below its own long-run level, and by the company’s own account the repair in its commercial business is a multi-year job rather than a finished one.

UnitedHealth (UNH) has returned about 67% over the last twelve months, and it now trades about 6% below its 52-week high. Anyone who has held through that run is carrying one question: has the profit margin come back the way the share price has? On the company’s own reported numbers the margin has not, and its own account of the commercial repair explains why.

Four Cents Of Operating Profit Where There Used To Be Eight

Measured through the June 2026 quarter, UnitedHealth’s operating margin is 4.2% against a 14-year company history of 8.0%, with gross margin at 18.8% against 24.2%; taken across its metrics, the combination sits further from that record than any prior reading. The medical care ratio did improve, to 86.7% in the June quarter from 89.4% a year earlier, though $860 million of net favorable prior period medical development, the majority of it in-year, helped it there. That is the shape of the recovery so far: real, assisted, and a long way from the old margin. Whether a business keeps earning what it used to earn is the whole test of a compounder, and on that test this one is not there yet.

Where The Cost Recovery Is Taking Longer

In its commercial benefits business, medical cost trend is running modestly above 11%, and management names the mechanisms: arbitration under the No Surprises Act, where the average award to an out-of-network provider is now 11 times what Medicare would pay, and heavier provider coding of office visits and emergency department care. Neither is a quick fix, and the sticky trend has pushed full commercial margin recovery past 2027. Medicare is the part that works: the margin on that product line, not the company-wide one, is guided to finish 2026 above 3%. Medical cost trend there is running below plan, helped by benefit design, network curation and a lighter respiratory season, even as Medicare Advantage enrollment declines. The squeeze is not only medical: the operating cost ratio moved the wrong way, 12.7% in the June quarter against 12.3% a year earlier, as technology and AI spending went in. Margins that hold up are one of the things the Trefis High Quality Portfolio insists on in its holdings.

Guidance Moved Up, The Margin Did Not

Management has put guidance behind the improvement. UnitedHealth has guided full-year 2026 adjusted earnings to a range of $19.50 to $20 a share and raised the outlook for Optum Health, the arm that delivers primary and specialist care, ambulatory surgery and home health, to at least $2.2 billion of full-year operating earnings. What the guidance does not do is put the old margin back, and that is the gap between a share price that has recovered and a business that has not.

A holder deciding whether to add here can see how the whole picture scores on the five-factor scorecard. The number to watch is the medical care ratio: the company guides 88.1% for full-year 2026, plus or minus 25 basis points, against 86.7% in the June quarter, and a finish above that range would say the reset is the level rather than the dip.

How Much Damage Could One Position Do To Your Net Worth?

Most portfolios hold a position that has quietly grown larger than anyone planned. A position that has grown large enough to matter is worth sizing deliberately rather than by accident. What a position that size would do to your net worth is exactly what the Trefis Wealth team computes, with the same rules-based systematic discipline that runs our High Quality Portfolio. Request a free vulnerability audit of your biggest positions.